IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Druss who wrote (67)	4/28/1997 9:42:00 PM
From: Mark B. Martell, CCM	of 1510

Druss, Robert The call was at 2:30PM. I still can't get details on it. All I've heard so far is that Remune is being rushed to market, and that Gallo is supporting the push through Phase III. Merck and Glaxo are co-marketers. There also was some conversation about another compound for arthritis which has received some great indications in trials. Again, I have no solid evidence, just someone telling me about the conference call. Market still seems to be unaware of this call. I wonder what's going on here. There's no information on IMNR's web site about this, nor anything in PR, Dow, etc. As soon as I hear anything, I'll post. Go IMNR. Looks like a buying op, given the weak close. If Remune is a strong Aids fighter with Gallo's support, sales won't be too long to follow. Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next